?? |
?? ?? |
CAS |
MF |
![GLPG0634](/CAS/20150408/GIF/1206101-20-3.gif) |
GLPG0634 |
1206101-20-3 |
C23H18N6O2 |
![Filgotinib](/CAS/GIF/1206161-97-8.gif) |
Filgotinib |
1206161-97-8 |
C21H23N5O3S |
![AR-42](/CAS/GIF/935881-37-1.gif) |
AR-42 |
935881-37-1 |
C18H20N2O3 |
![tasquinimod](/CAS/20150408/GIF/254964-60-8.gif) |
tasquinimod |
254964-60-8 |
C20H17F3N2O4 |
![PI3K/HDAC Inhibitor](/CAS/GIF/1339928-25-4.gif) |
PI3K/HDAC Inhibitor |
1339928-25-4 |
C23H24N8O4S |
![JNJ-26481585](/CAS/GIF/875320-29-9.gif) |
JNJ-26481585 |
875320-29-9 |
C21H26N6O2 |
![PCI 34051](/CAS/GIF/950762-95-5.gif) |
PCI 34051 |
950762-95-5 |
C17H16N2O3 |
![SCRIPTAID](/CAS/GIF/287383-59-9.gif) |
SCRIPTAID |
287383-59-9 |
C18H18N2O4 |
![2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-](/CAS/GIF/404951-53-7.gif) |
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
404951-53-7 |
C22H25N3O3 |
![4SC-201](/CAS/20150408/GIF/864814-88-0.gif) |
4SC-201 |
864814-88-0 |
C16H19N3O4S |
![EPZ004777](/CAS/20150408/GIF/1338466-77-5.gif) |
EPZ004777 |
1338466-77-5 |
C28H41N7O4 |
![GSK 343](/CAS/20150408/GIF/1346704-33-3.gif) |
GSK 343 |
1346704-33-3 |
C31H39N7O2 |
![UNC 1999](/CAS/20150408/GIF/1431612-23-5.gif) |
UNC 1999 |
1431612-23-5 |
C33H43N7O2 |
![1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide](/CAS/GIF/1396772-26-1.gif) |
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
1396772-26-1 |
C32H37N5O3 |
![UNC 0631](/CAS/20150408/GIF/1320288-19-4.gif) |
UNC 0631 |
1320288-19-4 |
C37H61N7O2 |
![Tazemetostat (EPZ-6438)](/CAS/20150408/GIF/1403254-99-8.gif) |
Tazemetostat (EPZ-6438) |
1403254-99-8 |
C34H44N4O4 |
![ZOTAROLIMUS](/CAS/GIF/221877-54-9.gif) |
ZOTAROLIMUS |
221877-54-9 |
C52H79N5O12 |
![N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea](/CAS2/GIF/1144068-46-1.gif) |
N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea |
1144068-46-1 |
C27H33N7O4 |
![PHA767491????](/CAS/GIF/845714-00-3.gif) |
PHA767491???? |
845714-00-3 |
C12H11N3O |
![CH5132799](/CAS/20150408/GIF/1007207-67-1.gif) |
CH5132799 |
1007207-67-1 |
C15H19N7O3S |
![Abemaciclib mesylate (LY2835219)](/CAS/GIF/1231930-82-7.gif) |
Abemaciclib mesylate (LY2835219) |
1231930-82-7 |
C28H36F2N8O3S |
![AVL-292](/CAS/20150408/GIF/1202757-89-8.gif) |
AVL-292 |
1202757-89-8 |
C22H22FN5O3 |
![PD0332991???????](/CAS/20180713/GIF/827022-33-3.gif) |
PD0332991??????? |
827022-33-3 |
C26H35N7O6S |
![PIK-294](/CAS/GIF/900185-02-6.gif) |
PIK-294 |
900185-02-6 |
C28H23N7O2 |
![LY 2874455](/CAS/20150408/GIF/1254473-64-7.gif) |
LY 2874455 |
1254473-64-7 |
C21H19Cl2N5O2 |
![PKI-402](/CAS/20150408/GIF/1173204-81-3.gif) |
PKI-402 |
1173204-81-3 |
C29H34N10O3 |
![N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea](/CAS/GIF/1207360-89-1.gif) |
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
1207360-89-1 |
C24H32N6O3 |
![BMS-265246](/CAS/GIF/582315-72-8.gif) |
BMS-265246 |
582315-72-8 |
C18H17F2N3O2 |
![Ribociclib](/CAS/20150408/GIF/1211441-98-3.gif) |
Ribociclib |
1211441-98-3 |
C23H30N8O |
![A66](/CAS/GIF/1166227-08-2.gif) |
A66 |
1166227-08-2 |
C17H23N5O2S2 |
![VS-5584](/CAS/20150408/GIF/1246560-33-7.gif) |
VS-5584 |
1246560-33-7 |
C17H22N8O |
![9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one](/CAS/GIF/1223001-51-1.gif) |
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one |
1223001-51-1 |
C24H15F3N4O |
![Torin 1](/CAS/GIF/1222998-36-8.gif) |
Torin 1 |
1222998-36-8 |
C35H28F3N5O2 |
![NVP-BGT226](/CAS/GIF/1245537-68-1.gif) |
NVP-BGT226 |
1245537-68-1 |
C28H25F3N6O2.C4H4O4 |
![BAY 80-6946 (Copanlisib)](/CAS/20150408/GIF/1032568-63-0.gif) |
BAY 80-6946 (Copanlisib) |
1032568-63-0 |
C23H28N8O4 |
![PURVALANOL A](/CAS/GIF/212844-53-6.gif) |
PURVALANOL A |
212844-53-6 |
C19H25ClN6O |
![REVERSINE](/CAS/GIF/656820-32-5.gif) |
REVERSINE |
656820-32-5 |
C21H27N7O |
![TG003](/CAS/GIF/300801-52-9.gif) |
TG003 |
300801-52-9 |
C13H15NO2S |
![AS 604850](/CAS/GIF/648449-76-7.gif) |
AS 604850 |
648449-76-7 |
C11H5F2NO4S |
![AMG 458](/CAS/20150408/GIF/913376-83-7.gif) |
AMG 458 |
913376-83-7 |
C30H29N5O5 |
![5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione](/CAS/GIF/958852-01-2.gif) |
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
958852-01-2 |
C18H11N3O2S |
![GNF 5837](/CAS/20150408/GIF/1033769-28-6.gif) |
GNF 5837 |
1033769-28-6 |
C28H21F4N5O2 |
![2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid](/CAS2/GIF/1173900-33-8.gif) |
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
1173900-33-8 |
C22H24N4O4 |
![NVP-BHG712](/CAS/GIF/940310-85-0.gif) |
NVP-BHG712 |
940310-85-0 |
C26H20F3N7O |
![Tepotinib](/CAS/GIF/1100598-32-0.gif) |
Tepotinib |
1100598-32-0 |
C29H28N6O2 |
![TAK-285](/CAS/20150408/GIF/871026-44-7.gif) |
TAK-285 |
871026-44-7 |
C26H25ClF3N5O3 |
![CZC24832](/CAS/20150408/GIF/1159824-67-5.gif) |
CZC24832 |
1159824-67-5 |
C15H17FN6O2S |
![XL765](/CAS/20150408/GIF/1349796-36-6.gif) |
XL765 |
1349796-36-6 |
C31H29N5O6S |
![4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide](/CAS2/GIF/844442-38-2.gif) |
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide |
844442-38-2 |
C16H17Cl2N5O2 |
![3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol](/CAS2/GIF/677297-51-7.gif) |
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol |
677297-51-7 |
C18H14N6O2 |
![PHA-848125](/CAS/GIF/802539-81-7.gif) |
PHA-848125 |
802539-81-7 |
C25H32N8O |
![WYE-354](/CAS/GIF/1062169-56-5.gif) |
WYE-354 |
1062169-56-5 |
C24H29N7O5 |
![5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine](/CAS/GIF/1224844-38-5.gif) |
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
1224844-38-5 |
C15H15N7O |
![PIK-75 Hydrochloride](/CAS/20150408/GIF/372196-77-5.gif) |
PIK-75 Hydrochloride |
372196-77-5 |
C16H15BrClN5O4S |
![Sanggenon C](/CAS/GIF/80651-76-9.gif) |
Sanggenon C |
80651-76-9 |
C40H36O12 |
![(R,10E)-4,8,9,12-Tetrahydro-3,11-dimethyl-6H-4,7-methenofuro[3,2-c]oxacycloundecin-6-one](/CAS/GIF/728-61-0.gif) |
(R,10E)-4,8,9,12-Tetrahydro-3,11-dimethyl-6H-4,7-methenofuro[3,2-c]oxacycloundecin-6-one |
728-61-0 |
C15H16O3 |
![Sinapine thiocyanate](/CAS/GIF/7431-77-8.gif) |
Sinapine thiocyanate |
7431-77-8 |
C17H24N2O5S |
![BMS-754807](/CAS/GIF/1001350-96-4.gif) |
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
![???????](/) |
??????? |
85085-22-9 |
|
![??????A](/CAS/20180808/GIF/88182-33-6.gif) |
??????A |
88182-33-6 |
C24H28O4 |
![????(E7050)](/CAS/GIF/928037-13-2.gif) |
????(E7050) |
928037-13-2 |
C33H37F2N7O4 |
![2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE](/CAS/GIF/189224-48-4.gif) |
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE |
189224-48-4 |
C13H14N2O |
![ligustroflavone](/CAS/20180808/GIF/260413-62-5.gif) |
ligustroflavone |
260413-62-5 |
C33H40O18 |
![2'-HYDROXYFLAVANONE](/CAS/GIF/17348-76-4.gif) |
2'-HYDROXYFLAVANONE |
17348-76-4 |
C15H12O3 |
![WZ8040](/CAS/GIF/1214265-57-2.gif) |
WZ8040 |
1214265-57-2 |
C24H25ClN6OS |
![Insulin-like Growth Factor-1 Receptor Inhibitor](/CAS/20181012/GIF/468740-43-4.gif) |
Insulin-like Growth Factor-1 Receptor Inhibitor |
468740-43-4 |
C25H26ClN5O3 |
![5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/GIF/475488-23-4.gif) |
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
475488-23-4 |
C28H31N5O |
![OSI-420](/CAS/20210111/GIF/183320-51-6.gif) |
OSI-420 |
183320-51-6 |
C21H22ClN3O4 |
![BULLATINE A](/) |
BULLATINE A |
1354-84-3 |
C22H33NO2 |
![AVP-AEW541](/CAS/GIF/475489-16-8.gif) |
AVP-AEW541 |
475489-16-8 |
C27H29N5O |
![ALK/IGF1R inhibitor](/CAS/20150408/GIF/1356962-20-3.gif) |
ALK/IGF1R inhibitor |
1356962-20-3 |
C24H25ClN6O |
![ZM 306416](/CAS/GIF/690206-97-4.gif) |
ZM 306416 |
690206-97-4 |
C16H13ClFN3O2 |
![licarin B](/CAS/GIF/51020-87-2.gif) |
licarin B |
51020-87-2 |
C20H20O4 |
![????????](/CAS/20180808/GIF/102841-42-9.gif) |
???????? |
102841-42-9 |
C26H32O14 |
![3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon](/CAS/GIF/194413-58-6.gif) |
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon |
194413-58-6 |
C15H14N2O |
![AMG-208](/CAS/GIF/1002304-34-8.gif) |
AMG-208 |
1002304-34-8 |
C22H17N5O2 |
![KRN 633](/CAS/20150408/GIF/286370-15-8.gif) |
KRN 633 |
286370-15-8 |
C20H21ClN4O4 |
![LiriopeMuscaribaily???C](/CAS/20210111/GIF/87480-46-4.gif) |
LiriopeMuscaribaily???C |
87480-46-4 |
C44H70O16 |
![R428](/CAS/20150408/GIF/1037624-75-1.gif) |
R428 |
1037624-75-1 |
C30H34N8 |
![YANGONIN](/CAS/GIF/500-62-9.gif) |
YANGONIN |
500-62-9 |
C15H14O4 |
![CLINODISIDE A](/CAS/20180906/GIF/916347-31-4.gif) |
CLINODISIDE A |
916347-31-4 |
C48H78O19 |
![7-Methoxyflavone](/CAS/GIF/22395-22-8.gif) |
7-Methoxyflavone |
22395-22-8 |
C16H12O3 |
![Periplocoside](/CAS/GIF/13137-64-9.gif) |
Periplocoside |
13137-64-9 |
C36H56O13 |
![????](/CAS/GIF/6754-58-1.gif) |
???? |
6754-58-1 |
C21H22O5 |
![CP-724714](/CAS/GIF/537705-08-1.gif) |
CP-724714 |
537705-08-1 |
C27H27N5O3 |
![OSI-930](/CAS/GIF/728033-96-3.gif) |
OSI-930 |
728033-96-3 |
C22H16F3N3O2S |
![NVP-BVU 972](/CAS/GIF/1185763-69-2.gif) |
NVP-BVU 972 |
1185763-69-2 |
C20H16N6 |
![DELPHINIDIN CHLORIDE](/CAS/GIF/528-53-0.gif) |
DELPHINIDIN CHLORIDE |
528-53-0 |
C15H11ClO7 |
![TYRPHOSTIN AG 1024](/CAS/GIF/65678-07-1.gif) |
TYRPHOSTIN AG 1024 |
65678-07-1 |
C14H13BrN2O |
![PD153035 HCl](/CAS/GIF/183322-45-4.gif) |
PD153035 HCl |
183322-45-4 |
C16H14BrN3O2.HCl |
![ARRY-380](/CAS/GIF/937265-83-3.gif) |
ARRY-380 |
937265-83-3 |
C29H27N7O4S |
![N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine](/CAS/GIF/1097917-15-1.gif) |
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
1097917-15-1 |
C29H40N8O3S |
![ISOBERGAPTEN](/CAS/GIF/482-48-4.gif) |
ISOBERGAPTEN |
482-48-4 |
C12H8O4 |
![IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea](/CAS/GIF/196868-63-0.gif) |
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
196868-63-0 |
C18H16ClN3O2 |
![5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine](/CAS2/GIF/870483-87-7.gif) |
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine |
870483-87-7 |
C20H22N4O3 |
![1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine](/CAS2/GIF/343787-29-1.gif) |
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine |
343787-29-1 |
C24H27N5O2 |
![GSK1838705A](/CAS/20180713/GIF/1116235-97-2.gif) |
GSK1838705A |
1116235-97-2 |
C27H29FN8O3 |
![3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione](/CAS/GIF/905854-02-6.gif) |
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione |
905854-02-6 |
C23H19N3O2 |
![Icotinib](/CAS/GIF/610798-31-7.gif) |
Icotinib |
610798-31-7 |
C22H21N3O4 |
![Capmatinib](/CAS/GIF/1029712-80-8.gif) |
Capmatinib |
1029712-80-8 |
C23H17FN6O |